Healthcare Services Group, Inc. HCSG
Set alert
25.76 USD +1.24 +5.06%
At close · Nov 2
25.60 -0.16 -0.62%
After hours · Nov 2, 4:12 PM ET
24.97 Day range 25.79
16.78 52-week range 25.79
- YTD
- +34.73%
- 1 year
- +44.15%
- Open
- 25.00
- Prev close
- 24.52
- Mkt cap
- 1.74B
- Vol
- 671.95K
- Avg vol
- 732.63K
- EPS
- 1.48
- P/E
- 17.41
- Div yield
- 0.00%
More statistics
- Low
- 24.97
- High
- 25.79
- Forward P/E
- 20.54
- Beta
- 0.91
- Short ratio
- 3.64
- Inst. own
- 116.31%
- Dividend
- 0.00
- Ex-div date
- Nov 16, 2022
- Earnings
- Feb 10, 2027
- 50-d avg
- 21.97
- 200-d avg
- 21.40
- 1y target
- 26.67
5D chart
Signals (113)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 12:55 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 11:40 AM | 14 hours ago |
| RSI: Overbought | Nov 2, 11:10 AM | 15 hours ago |
| MACD: Buy Signal | Nov 2, 11:05 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 10:45 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 10:35 AM | 15 hours ago |
| MACD: Sell Signal | Nov 2, 10:35 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 16 hours ago |
| RSI: Overbought | Nov 2, 10:20 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 16 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 16 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 16 hours ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:40 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:25 PM | 3 days ago |
Newest 20 of 113.
Analyst view
Consensus: buy
Buy
Price target (mean) 26.67 +3.5% upside
Now 25.76
- Target (low)
- 24.00
- Target (mean)
- 26.67
- Target (high)
- 30.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
- Strong buy0
- Buy4
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.27127 | 0.24 – 0.30 | 0.44 | -38.3% | 537.85M | +15.3% | 7 |
| Next quarter | 0.295 | 0.26 – 0.31 | 0.37 | -20.3% | 533.20M | +15.2% | 4 |
| Current year | 1.34 | 1.29 – 1.46 | 0.81 | +65.1% | 1.95B | +6.2% | 7 |
| Next year | 1.25 | 1.09 – 1.37 | 1.34 | -6.2% | 2.18B | +11.7% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2026 | Baird | Maintained | Neutral | Neutral |
| Aug 19, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| Apr 23, 2026 | UBS | Maintained | Buy | Buy |
| Apr 23, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Apr 23, 2026 | Benchmark | Maintained | Buy | Buy |
| Apr 23, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Mar 3, 2026 | RBC Capital | Initiated | — | Sector Perform |
| Nov 13, 2025 | BMO Capital | Initiated | — | Market Perform |
| Oct 28, 2025 | UBS | Maintained | Buy | Buy |
| Oct 23, 2025 | Benchmark | Maintained | Buy | Buy |
| Jul 29, 2025 | Macquarie | Upgrade | Neutral | Outperform |
| Jul 24, 2025 | Benchmark | Maintained | Buy | Buy |
| Jul 24, 2025 | Baird | Maintained | Neutral | Neutral |
| Apr 28, 2025 | Macquarie | Maintained | Neutral | Neutral |
| Apr 24, 2025 | Baird | Maintained | Neutral | Neutral |
| Apr 24, 2025 | UBS | Upgrade | Neutral | Buy |
| Dec 19, 2024 | Benchmark | Reiterated | Buy | Buy |
| Dec 16, 2024 | Macquarie | Initiated | — | Neutral |
| Oct 24, 2024 | Benchmark | Reiterated | Buy | Buy |
| Oct 24, 2024 | Baird | Maintained | Neutral | Neutral |
| Jul 25, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jul 25, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 25, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 15, 2024 | Benchmark | Maintained | Buy | Buy |
| Feb 15, 2024 | UBS | Maintained | Neutral | Neutral |
| Feb 15, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 22, 2023 | Benchmark | Reiterated | Buy | Buy |
| Nov 30, 2023 | UBS | Initiated | — | Neutral |
